Immune checkpoint inhibitors and timing of administration

被引：0
|
作者：
Dizman, Nazli [1 ]
Velazquez, Ana, I [2 ]
Duma, Narjust [3 ]
机构：
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06511 USA
[2] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E56 / E56
页数：1
相关论文
共 50 条
  • [1] Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?
    Karaboue, Abdoulaye
    Innominato, Pasquale F.
    Wreglesworth, Nicholas I.
    Duchemann, Boris
    Adam, Rene
    Levi, Francis A.
    BRITISH JOURNAL OF CANCER, 2024, : 783 - 796
  • [2] Administration of Immune Checkpoint Inhibitors Near the End of Life
    Bloom, Matthew D.
    Saker, Haneen
    Glisch, Chad
    Ramnaraign, Brian
    George, Thomas J.
    Markham, Merry J.
    Kelkar, Amar H.
    JCO ONCOLOGY PRACTICE, 2022, 18 (06) : 445 - +
  • [3] The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations
    Hadfield, Matthew J.
    Benjamin, David J.
    Krell, Jonathan
    Warner, Jeremy
    Lythgoe, Mark P.
    TRENDS IN CANCER, 2024, 10 (07) : 579 - 583
  • [4] Immune Checkpoint Inhibitors
    Haanen, John B. A. G.
    Robert, Caroline
    IMMUNO-ONCOLOGY, 2015, 42 : 55 - 66
  • [5] Immune checkpoint inhibitors
    Hui, Enfu
    JOURNAL OF CELL BIOLOGY, 2019, 218 (03): : 740 - 741
  • [6] Immune checkpoint inhibitors
    Kitano, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1305 - S1305
  • [7] Immune Checkpoint Inhibitors
    West, Howard
    JAMA ONCOLOGY, 2015, 1 (01) : 115 - 115
  • [8] Immune checkpoint inhibitors
    Kroemer, Guido
    Zitvogel, Laurence
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (03):
  • [9] Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report
    Leblanc, Julie
    Hoibian, Solene
    Boucraut, Agathe
    Ratone, Jean-Philippe
    Stoffaes, Louis
    Dano, Domitille
    Louvel-Perrot, Delphine
    Chanez, Brice
    Chretien, Anne-Sophie
    Madroszyk, Anne
    Rochigneux, Philippe
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer
    Maslov, Diana, V
    Tawagi, Karine
    Madhav, K. C.
    Simenson, Victoria
    Yuan, Helen
    Parent, Cameron
    Bamnolker, Adi
    Goel, Richa
    Blake, Zoe
    Matrana, Marc R.
    Johnson, Daniel H.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
12345